Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation ... and future implant solutions”. The global ...